ReviewDiabetologia2026
Islet ultrastructure: past achievements and future directions.
Review in Diabetologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Islets of Langerhans constitute the endocrine component of the pancreas and comprise the main cell types responsible for the regulation of glucose homeostasis. Beta cells produce and secrete insulin, the principal hormone capable of lowering blood glucose. However, the interplay of beta cells with other endocrine cell types, such as alpha cells and delta cells, is critical for proper blood glucose regulation. The failure of beta cells to produce sufficient amounts of insulin leads to diabetes, a major metabolic disease. Since their discovery by Paul Langerhans using a simple light microscope in 1869, islets have been imaged using many different modalities. From the middle of the 20th century, electron microscopy has been a key tool in resolving the ultrastructure of islet cells, thereby making important contributions to the understanding of protein trafficking in general, and islet cell function as well as dysfunction in diabetes. Recent advances in microscopy techniques as well as the broader availability of analysis tools have elevated islet imaging from two dimensions into three dimensions and enable nanoscale imaging within the tissue context. Here, we review work on islet ultrastructure, from landmark studies published in the 1960s and 1970s to recent advances in imaging. Finally, we discuss open questions and propose ideas for integrating different modalities into structural imaging with the goal of better understanding islet function and dysfunction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.